BridgeBio Pharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BridgeBio Pharma, Inc. has filed 814 SEC EDGAR filings since 19 Jun 2018

SEC filing history

Showing 226-250 of 814 matching filings.

Per page
25
Current page
10
4

4

Filing date
19 Feb 2025
Reporting date
16 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 Feb 2025
Reporting date
16 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 Feb 2025
Reporting date
16 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38959

144 filing

Filing date
19 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38959

144 filing

Filing date
19 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91059

SCHEDULE 13G/A filing

Filing date
13 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91059

SCHEDULE 13D/A filing

Filing date
31 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38959

144 filing

Filing date
31 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2025
Reporting date
31 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Jan 2025
Reporting date
28 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Jan 2025
Reporting date
28 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38959

144 filing

Filing date
28 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38959

144 filing

Filing date
28 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A

Filing date
08 Jan 2025
Reporting date
26 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
31 Dec 2024
Reporting date
30 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Dec 2024
Reporting date
26 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Dec 2024
Reporting date
24 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Dec 2024
Reporting date
10 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Dec 2024
Reporting date
10 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Dec 2024
Reporting date
10 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Nov 2024
Reporting date
19 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Nov 2024
Reporting date
19 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 Nov 2024
Reporting date
16 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .